[Are high levels of HDL always associated with a reduced risk of myocardial infarction? - lipid therapy should still focus on lowering LDL cholesterol levels].
Universitätsklinikum des Saarlandes Homburg/Saar.
Ulrich
U
Laufs
D000924:Anticholesteremic Agents / Q000627:therapeutic use*; D008076:Cholesterol, HDL / Q000097:blood*; D008078:Cholesterol, LDL / Q000097:blood*; D006801:Humans; D006937:Hypercholesterolemia / Q000097:blood* / Q000453:epidemiology* / Q000235:genetics / Q000517:prevention & control; D008049:Lipase / Q000235:genetics; D009203:Myocardial Infarction / Q000097:blood* / Q000453:epidemiology* / Q000235:genetics / Q000517:prevention & control; D016017:Odds Ratio; D011110:Polymorphism, Genetic; D020641:Polymorphism, Single Nucleotide / Q000235:genetics; D012306:Risk
D000924:Anticholesteremic Agents; D008076:Cholesterol, HDL; D008078:Cholesterol, LDL; C410382:LIPG protein, human; D008049:Lipase